Valeant shakeup continues, hires Zoetis's Paul Herendeen as CFO – The Globe and Mail + MORE Aug 22nd

TSX getting you down? There are always sound investment alternatives.
Latest News

GICs and Savings Accounts - Which Best Combat Inflation? Sep 7th

Guaranteed Investment Certificates (GICs) and Savings accounts at banks offer a person in Canada the safest possible place to invest money. Both are backed 100% against any loss up to $100,000 by the Canada Deposit Insurance Corporation, an arm of the federal government. That's as safe as it gets.Sa.... More »

2023 tax credits, due dates and when you can file: Your 2023 income tax return guide Apr 9th

You’ll want to bookmark the MoneySense guide for 2023 personal income taxes. We will be updating it frequently, as information becomes available and deadlines approach. Plus, we get answers from the experts you won’t find anywhere else, thanks to our Ask MoneySense and Ask A Planner columns.&nbs.... More »

Royal Bank hikes dividend as it reports $3.2B net income in first quarter Feb 22nd

Royal Bank of Canada raised its dividend as it reported quarterly net income of $3.17 billion, up from $3.01 billion a year ago, matching market expectations as market volatility during the period weighed on its earnings..... More »

Take control of your finances with these budgeting tips for young adults + MORE Nov 28th

As you start your career and earn a living, you’ll have to figure out how to manage your money on your own. It’s not uncommon to look at your bank balance and wonder where all your money went, even though you just got paid. That’s why you’ll want to create a budget. According to an RBC p.... More »
LAVAL, Que. – Valeant Pharmaceuticals Inc. (TSX:VRX) has appointed Paul Herendeen as its new chief financial officer, effective immediately, and reassigned the man who has been its CFO through a tumultuous period.
Robert Rosiello, who was appointed Valeant’s CFO on July 1 of last year will remain at Valeant as executive vice-president for corporate development and strategy, reporting to CEO Joseph Papa, who joined the company in late April.
The Quebec-based company is working to recover from a series of problems that emerged last September and continued into this year, driving down the company’s market value by about 90 per cent since last August.
Last week, Valeant’s major lenders agreed to give the company more flexibility to sell assets and make additional short-term borrowing as its seeks to reduce its debt load and defends itself from multiple allegations of improper accounting practices.
Herendeen comes to the Laval-based company from Zoetis, a Pfizer spinoff that specializes in animal health, where he was executive vice-president and CFO for two years…

Continue Reading On canadianbusiness.com »

A U.S. national security panel has cleared ChemChina’s $43-billion takeover of Swiss pesticides and seeds group

Continue Reading On theglobeandmail.com »

6 questions to ask before and during your home inspection(iStock)
Your first line of defence in avoiding a bad property investment is the home inspection report. To get the most out of this report you need to do two things: Be present and ask questions.
While a recent announcement by the Ontario Minister of Government and Consumer Services will see the introduction of laws to establish minimum standards for home inspections, this doesn’t mean a homebuyer can neglect their own due diligence. This new legislation proposes to set minimum licensing standards for the roughly 1,500 home inspectors that work in Ontario, and will include a regulations on what information needs to be disclosed to home buyers, as well as regulate the language inspectors can use in their contracts.
But even homebuyers in provinces without inspector regulation can be proactive about avoiding the money-pit nightmare.
Be present during the home inspection
The most important rule is to be present during the home inspection. This means scheduling time off from work and family responsibilities, and shutting off the phone, during the couple of hours the inspector is present at the home you hope to buy…

Continue Reading On moneysense.ca »

The Globe and MailValeant shakeup continues, hires Zoetis's Paul Herendeen as CFOThe Globe and MailThe shakeup in the executive ranks at Valeant Pharmaceuticals International Inc. continues with the appointment of a new chief financial officer. The Laval, Que.-based drug giant said on Monday it has hired Paul Herendeen as executive vice-president, …Valeant names former Zoetis CFO as new finance chiefCTV NewsValeant, attempting to normalize operations, names new CFOTheChronicleHerald.caValeant (VRX) Stock Climbs, Hires Zoetis' Herendeen as CFOTheStreet.comBloomberg -Wall Street Journal (blog) -MarketWatch -Reutersall 28 news articles »

Continue Reading On Theglobeandmail.com »

BRAMPTON, Ont. – Loblaw Companies Ltd. (TSX:L) is planning another acquisition in the health-care industry — offering $170 million to buy a B.C.-based company that provides secure medical records technology.
The Canadian grocery and pharmacy giant is offering $3.10 cash per share of QHR Corp. of Kelowna, B.C. (TSXV:QHR) — 22 per cent above the stock’s closing price Friday on the TSX Venture Exchange.
Loblaw says QHR is a “natural complement” to its Shoppers Drug Mart business — which operates Canada’s largest retail network of pharmacies.
QHR currently supports 7,700 health-care providers with a suite of secure medical records technology.
Its board of directors is supporting the Loblaw takeover bid but the deal requires approval from at least two-thirds of the votes cast by QHR shareholders at a special meeting to be held in October.
The post Loblaw makes $170-million cash bid for B.C. medical records company QHR Corp. appeared first on Canadian Business – Your Source For Business News.

Continue Reading On canadianbusiness.com »

Share

PinIt
Compare insurance quotes through Kanetix.ca - save time and money!